Skip to content
Governance Register

← US public companies

Polaris Venture Management Co. V, L.L.C.

SEC-identified person · CIK 1439589 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Invivyd, Inc. IVVD Officer filed 2022–2022
Lyra Therapeutics, Inc. LYRA Officer filed 2020–2020
Phreesia, Inc. PHR Officer filed 2019–2019
Cardlytics, Inc. CDLX Director filed 2018–2019
Ruthigen, Inc. RTGN Officer filed 2015–2018
X4 Pharmaceuticals, Inc XFOR Officer filed 2017–2017
Kala Pharmaceuticals, Inc. KALA Officer filed 2017–2017
Selecta Biosciences INC SELB Officer filed 2016–2016
T2 Biosystems, Inc. TTOO Officer filed 2014–2015
Genocea Biosciences, INC. GNCA Officer filed 2014–2015
Atyr Pharma INC LIFE Officer filed 2015–2015
Ocular Therapeutix, INC OCUL Officer filed 2014–2015
Trevena INC TRVN Officer filed 2014–2014
Dare Bioscience, Inc. DARE Officer filed 2014–2014
Fate Therapeutics INC fate Officer filed 2013–2013
Dnib Unwind, INC. BIND Officer filed 2013–2013
Internet Brands, INC. INET Officer filed 2008–2008

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.